Board Member

Dr. John Chant



“Nothing would make me more satisfied than to know we have given others a longer, healthier life with happiness.”

Dr. Chant joined Filtricine as CEO in December 2020. As a successful entrepreneur, he saw incredible potential in Filtricine and Tality. He decided to lead this revolutionary nutrition-based approach to cancer care. Previously, Dr. Chant served as founder/CEO of two successful oncology startups: G1 Therapeutics (NASDAQ: GTHX) and Gatekeeper Pharmaceuticals.  In 2018 he spun out AlphaEleven Therapeutics from the University of California San Francisco to commercialize inhibitors of clotting factor XI as next generation anticoagulants. He's held research and development positions with CuraGen and Genentech. Dr. Chant holds a PhD from the University of California San Francisco and served on the faculty of Harvard University early in his career.

Our Team

Dr. Xiyan Li
CSO & Co-founder
Dr. Jimmy Xin Wang
CTO & Co-founder
Dr. Grace Xiaolu Yang
COO, VP of Research & Co-founder
Mike Partsuf
Senior Food Scientist
Emily Sinovic
Public Relations Consultant
Todd Lorenz
Clinical Development Consultant

Our Advisors

Dr. Mike P Snyder
Chair of Genetics
Stanford University School of Medicine
Peter B Hutt
Former FDA Chief Counsel
Senior Counsel at Covington & Burling LLP
Brad Barnes
Culinary Institute of America
Dr. Dariush Mozaffarian
Dean at the School of Nutrition Science
Tufts University
Dr. Yung-Chi Cheng
Henry Bronson Professor of Pharmacology
Yale University School of Medicine
Dr. Danhua Xiao
Nutrition & Metabolic Physician Specialist
Atlantic Health Metabolic Center
Dr. Joseph V Rodricks
Founding Principal
Ramboll (formerly ENVIRON)
Alister Thomson
Bristol Myers Squibb (Former)
Jeff Depew
Board Director & Committee Chair
Sand Hill Angels
Dr. Wei Jiang
Senior Director
Medical Affairs at MorphoSys

Our Board of Directors

Dr. Xiyan Li
CSO & Co-founder
Dr. Rami El Assal
Founding Partner at Boutique Venture Partners
Drew Lanza
Founding Partner at Berkeley Catalyst Fund
We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.
© 2022 Filtricine, Inc. All Rights Reserved | by Wuilt